Lecanemab: A Humanized Monoclonal Antibody for the Treatment of Early Alzheimer Disease. Park J, Simpson C, Patel K. Ann Pharmacother 2023 Dec 14:10600280231218253. doi: 10.1177/10600280231218253.

Read + Share

Amedeo Smart

Independent Medical Education

Park J, Simpson C, Patel K. Lecanemab: A Humanized Monoclonal Antibody for the Treatment of Early Alzheimer Disease. Ann Pharmacother 2023 Dec 14:10600280231218253. doi: 10.1177/10600280231218253.
PMID: 38095619